Patients with COPD (Chronic obstructive pulmonary disease) and being administered with inhaled corticosteroids experienced lower mortality risk than their counterparts not on steroids, as per a new study published in the CHEST, peer-reviewed journal of the American College of Chest Physicians (ACCP).

It was remarked by Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada and author of this study that COPD patients on corticosteroids benefit from longer survival durations.

From Bio-medicine.org:

“Our results indicate that the effect of inhaled corticosteroids is relatively short-term and that those currently using it are relatively better protected, ” said Dr. Macie. “Inhaled corticosteroids should be prescribed as soon as clinically indicated. By treating COPD with inhaled corticosteroids, we have the potential to reduce the effect and prolong life.”

“The findings from this study are intriguing for clinicians and point to the need for further research to define the role and mechanisms of the effect of inhaled corticosteroids on both cardiovascular and respiratory mortality,” said W. Michael Alberts, MD, FCCP, President of the ACCP.

Dr. Macie also said that patients on inhaled corticosteroids are relatively better positioned to stay protected than those not using them.

Tags: chronic obstructive pulmonary disease, COPD, inhaled corticosteroids, steroids

Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids